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Abstract 
Purpose: To synthesize, characterize and investigate the antimicrobial properties of pure and 
manganese-doped zinc oxide nanoparticles.  
Method: Un-doped and manganese-doped zinc oxide (Mn-doped ZnO) nanoparticles were prepared 
using co-precipitation method. The synthesized Mn-doped ZnO nanoparticles were characterized using 
energy-dispersive x-ray spectroscopy (EDX), scanning electron microscopy (SEM), and x-ray diffraction 
(XRD) spectroscopic techniques. Their band gap energies were measured with ultraviolet-visible (UV-
Vis) spectroscopy, while their antioxidant properties were evaluated by ferric reducing antioxidant power 
(FRAP), DPPH radical-scavenging, ferric thiocyanate (FTC) and total phenolic content (TPC) assays. 
The antimicrobial activities of the nanoparticles against different bacterial strains were determined using 
agar diffusion method.  
Result: Results from XRD, SEM, EDX and UV-Vis analyses demonstrated successful synthesis of un-
doped and Mn-doped ZnO nanoparticles as seen in their hexagonal, wurtzite structures. The un-doped 
and Mn-doped ZnO nanoparticles had average grain sizes of 16.72 nm and 17.5 nm, and band gap 
energies of 3.585 eV and 2.737 eV, respectively. Significant antibacterial activity was manifested by Mn-
doped ZnO against E. coli, S. aureus, Klebsiella and B. subtilis, with zones of inhibition (ZOIs) of 13 ± 
0.09 mm, 14 ± 0.01 mm, 18 ± 0.07 mm and 20 ± 0.10 mm, respectively. The Mn-doped ZnO 
nanoparticles also exhibited effective and significant antioxidant potential relative to butylated 
hydroxytoluene (BHT) and un-doped ZnO nanoparticles.  
Conclusion: Mn-doped ZnO nanoparticles demonstrate significant antimicrobial and antioxidant 
activities. Thus, the preparation is a good candidate for further development into therapeutic 
formulations. 
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Zinc oxide (ZnO) nanoparticles have received 
much attention in recent years due to their 
diverse applications [1]. Nowadays, prototype 
ZnO nanoparticles are used as delivery systems 
for vaccines and anti-cancer drugs [2]; as 
antimicrobial agents, additives in industrial 
products and photo-catalysts for disintegrating 
organic materials [3]. However, ZnO 
nanostructures are still being widely studied with 
a view to enhancing their potential applications in 
the field of biomedicine [2].  
 
It has been reported that the functionality and 
efficiency of ZnO nanoparticles and 
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nanostructures can be improved by increasing 
and modifying their surface areas through nano-
scale addition of some dopants materials such as  
biomolecules and transition metals (Mn, Fe, Cr, 
Cu) [4]. This surface modification with 
biomolecules and transition metals confers new 
properties on ZnO nanoparticles so they can 
function as biosensors, antimicrobial, 
antioxidants, drug delivery systems and bio-
imaging materials [1,4,5].  
 
Different methods have been developed for the 
fabrication of un-doped ZnO and transition metal-
doped ZnO nanoparticles [6]. Manganese (Mn) is 
the metal of choice for doping of ZnO 
nanoparticles because of the ready availability of 
its d electrons at t2g level, and also for the fact 
that these electrons can easily overlap with the 
valance bond of ZnO nanoparticles [4,5].  
 
It has been demonstrated that if ZnO 
nanoparticles are doped with Mn, the products 
have enhanced antibacterial [2] and magnetic 
properties [3] which may be acceptable for 
biomedical and spintronic applications [4]. The 
enhancement of the antioxidant and antimicrobial 
properties is due to the fact that doping of ZnO 
nanoparticles with Mn increases the surface area 
and reduces particle size of ZnO nanoparticles 
[7], Thus, studies aimed at investigating the 
biological, optical, and magnetic properties of 
Mn-doped ZnO nanoparticles have attracted 
much interest [8].  
 
The purpose of the present study was to 
synthesize and characterize un-doped ZnO and 
Mn-doped ZnO nanoparticles, and investigate 




All chemicals and reagents used were procured 
from Sigma-Aldrich (United States of America) 
and Merck (Germany) and were of analytical 
grade. These reagents included butylated 
hydroxytoluene (BHT; 99.07% pure); 2, 2-
diphenyl-1-picrylhydrazyl (DPPH, 90.0% pure); 
Folin-Ciocalteu reagent (2N), linoleic acid and 
catechin. 
 
Preparation of solutions 
 
Zinc acetate [Zn(CH3COO)2.2H2O; 0.05M)] was 
prepared by dissolving 5.525 g of Zn-acetate in 
distilled water in a 500-mL volumetric flask, with 
solution level brought up to the mark, and then 
stirring for 10 min. Thereafter, 0.05M solution of 
magnesium acetate [Mn(CH3COO)2.4H2O] was 
prepared by dissolving 1.235 g of Mn-acetate in 
100 mL distilled water in a measuring flask, 
followed by vortexing. Ammonia solution (35 %) 
was also prepared in distilled water. 
 
Synthesis of un-doped ZnO nanoparticles 
 
Zinc acetate (0.05 M, 450mL) was put in a 1000-
mL beaker and stirred for 30 min at room 
temperature (30 oC) using magnetic stirrer at the 
rate of 2000 rpm. Diluted ammonia (35 %) was 
added slowly with constant stirring for 1 h, to a 
pH of about 10. After attaining the desired pH~ 
10, the reaction mixture was heated at 60 oC with 
continuous stirring for 30 min using magnetic 
stirrer at the rate of 2000 rpm. Then reaction 
mixture was placed at room temperature (28-30 
oC) for 48 h for precipitation to occur. This 
resulted in the formation of white colored 
precipitates in the reaction mixture. To separate 
the precipitates, the reaction mixture was filtered 
and washed thrice with distilled water, and then 
further washed thrice with 30 mL of ethanol to 
remove impurities. Thereafter, the precipitates 
were filtered and oven-dried at 110 oC for 1 h. 
The dried precipitates were milled using a pestle 
and mortar, and then the powder was heated in 
oven for 20 min at the same temperature (110 
oC) to remove any absorbed moisture. Then, 
calcination of the white powder was done at 200 
oC for 3 h in a muffle furnace. This yielded white 
and fine un-doped ZnO nanoparticles which were 
kept in air tight container at room temperature 
(25-30 oC). 
 
Synthesis of Mn-doped ZnO nanoparticles 
 
The zinc acetate and manganese acetate 
solutions were employed, and ammonia (35 %) 
was used to adjust the pH to 10. To 450 mL of 
0.05M Zn acetate in a 1000-mL beaker was 
slowly and continuously added, with stirring, 50 
mL of 0.05M Mn acetate. The reaction mixture 
was stirred for 30 min using magnetic stirrer at 
the rate of 2000 rpm. Diluted ammonia was then 
added from the burette to the reaction mixture, at 
a flow rate of 2 mL/min to attain pH~ 10. The 
reaction mixture was constantly stirred during the 
pH adjustment, at the rate 1000 rpm in a 
magnetic stirrer. After the pH adjustment, the 
solution was further stirred with the magnetic 
stirrer at the rate of 1500 rpm for 1 h. Then the 
reaction mixture was heated at 60 oC for 30 min, 
and placed at room temperature (28-30 oC) for 
48 h for precipitation to take place. This resulted 
in the formation of brown-colored precipitates in 
the reaction mixture. To separate out the 
precipitates, the reaction mixture was filtered and 
washed thrice with distilled water, and then 
washed thrice with 30 mL of ethanol to eliminate 
impurities. The precipitates were thereafter oven-
dried at 110 oC for 1 h, and milled in a pestle and 
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mortar. The brown, powdered nanoparticles were 
heated in an oven for 20 min at 110 oC to remove 
any traces of absorbed moisture. Then, 
calcination of the brown powder was done at 200 
oC for 3 h in a muffle furnace. This yielded brown 
and fine Mn-doped ZnO nanoparticles that were 
kept in an air-tight container at room temperature 
(25-30 oC) prior to use [9]. 
 
Characterization of un-doped and Mn-doped 
ZnO nanoparticles 
 
Energy dispersive X-ray technique was 
employed for the determination of the 
composition and morphology of the synthesized 
un-doped and Mn-doped ZnO nanoparticles. In 
addition, characterization of the crystalline 
structure of the nanoparticles was done using the 
XRD i.e. PANalytical X'Pert diffractometer 
instrument with Cu-Kα radiation (wavelength 
0.154 nm) operating at 40 kV and 30 mA. 
Measurements were scanned for diffraction 
angles (2θ) ranging from 20 to 90o with a step 
size of 0.02o and a time per step of 1 s. The 
absorption spectrum and band gap energies of 
the synthesized nanoparticles were determined 
by UV-visible spectrophotometer (Spectra Flash 
SF 550, Data color Inc., USA), while their 
morphological features were determined using 
SEM (Jeol, 5910LV). 
 
Evaluation of antioxidant activity 
 
DPPH free radical scavenging assay 
 
The antioxidant properties of the un-doped and 
Mn-doped ZnO nanoparticles were determined 
by 2, 2-diphenyl-1-picrylhydrazyl (DPPH) radical 
scavenging capacity according to the method of 
Khan et al [10]. Butylated hydroxytoluene (BHT) 
was used as standard for comparison. 
 
Total phenolic content (TPC) assay 
 
The total phenolic content of the Mnu-doped ZnO 
NAPs was determined colorimetrically as 
described by Khan et al [11]. 
 
Ferric reducing antioxidant power (FRAP) 
assay 
 
Antioxidant potential of un-doped and Mn-doped 
ZnO nanoparticles was also assessed by 
evaluating the ferric reducing antioxidant power 
as described by Ijaz et al [12]. 
 
Ferric thiocyanate (FTC) assay  
 
Antioxidant potential in terms of the inhibitory 
effect of the un-doped and Mn-doped ZnO 
nanoparticles on linoleic acid peroxidation was 
evaluated by the thiocyanate method of Ijaz et al. 
[12]. 
 
Evaluation of antibacterial activity  
 
The antibacterial properties of the synthesized 
un-doped and Mn-doped ZnO nanoparticles were 
evaluated by using the Agar well diffusion 
method of Khan et al [13, 14]. The bacterial 
strains used for the determination of bactericidal 
activities were Bacillus subtilis (B. subtitles), 
Escherichia coli (E. coli), Klebsiella and 
Staphylococcus aureus (S. aureus). S. aureus, 
Klebsiella and Bacillus subtilis represented 
Gram-positive bacteria while E. coli represented 
Gram-negative bacteria. Distilled water was used 
as negative control for the bacterial strains while 
bacteriological cephradine was used as standard 
antibiotic for positive control. Solutions of un-
doped ZnO and Mn-doped ZnO nanoparticles in 
distilled water were prepared through ultra-
sonication method. Two different concentrations 
of solutions (3 and 5 mg/mL) for the synthesized 
un-doped ZnO and Mn-doped ZnO nanoparticles 
were used for evaluating the antibacterial 
potential, and the results were compared with 
those obtained for the standard drug 
(cephradine). For the reference antibiotic, 1 mg 




Statistical analysis was done by one-way or two-
way ANOVA and the Tukey post-test using 
Graph Pad Prism v6.04 software (Graph Pad 
Software, Inc., La Jolla, CA, USA). Differences 
were considered statistically significant at 
p<0.05. Group sizes are indicated in the figure 




Characteristics of synthesized nanoparticles 
 
X-ray diffraction  
 
The XRD patterns for un-doped and Mn-doped 
ZnO nanoparticles are shown in Figure 1 (a) and 
Figure (b) respectively. The XRD pattern of un-
doped ZnO nanoparticles was uniform and no 
impurities were observed in the spectrum as 
shown in Figure 1(a).  Moreover, the XRD 
pattern showed intense and sharp peaks which 
confirmed the crystalline nature of the un-doped 
ZnO nanoparticles. The formation of phase 
indicates pure wurtzite structure of ZnO 
nanoparticles which was confirmed by XRD 
peaks 31.7, 34.35, and 36.15. As the highest 
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peak (36.15) is the major peak homologous to 
hexagonal wurtzite structure.  
 
The XRD results indicate good crystalline nature 
of un-doped ZnO nanoparticles because of 
intense and narrow peaks. The average grain 
size of un-doped ZnO nanoparticles was 16.72 
nm. Moreover, small broadening at the bottom of 
peaks indicated that the crystalline size was 
small [7]. The XRD pattern for Mn-doped ZnO 
nanoparticles is shown in Figure 1 (b). The XRD 
patterns of Mn-doped ZnO nanoparticles were 
similar to those of XRD pattern of un-doped ZnO 
nanoparticles. The XRD results demonstrated 
that the peaks were narrow and sharp which 
confirmed the crystalline nature of the 
synthesized Mn-doped ZnO nanoparticles.  
 
The average grain size for Mn-doped ZnO 
nanoparticles was 17.5 nm. The average size 
was slightly greater than that of the un-doped 
ZnO nanoparticles, obviously due to 
incorporation of Mn. Grain size depends on 
percentage of doping element. The formation of 
phase indicated pure wurtzite structure of Mn-
doped ZnO nanoparticles which was confirmed 
by XRD peaks 25.65, 29.80, 31.30, 33.95, and 
35.75. Figure 2(b) shows uniform XRD pattern, 
with no evidence of impurity in the Mn-doped 
ZnO nanoparticles [8]. The grain sizes of the un-
doped and Mn-doped ZnO nanoparticles were 




Figures 2 (a) and (b) show the surface 
morphological and structural patterns of un-
doped ZnO nanoparticles using scanning 
electron microscope (SEM). SEM micrograph for 
un-doped ZnO nanoparticles indicated that the 
un-doped ZnO nanoparticles were fine particles 
with crystalline behavior. Moreover, SEM results 
also confirmed that the synthesized un-doped 
ZnO nanoparticles had particles size in 
nanometer in range. 
 
Figure 2 (c) shows the micrograph for Mn-doped 
ZnO nanoparticles. SEM micrograph results 
demonstrated that the particle size of Mn-doped 
ZnO nanoparticles was slightly larger than that of 

































(a)                                                                         (b) 
Figure 1:  XRD pattern of un-doped ZnO (a) and Mn-doped ZnO nanoparticles (b) 
 
     
                       (a)                                                   (b)                                               (c) 
 
Figure 2: SEM micrographs of un-doped ZnO (a), (b) and Mn-doped ZnO nanoparticles (c) 
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the un-doped ZnO nanoparticles. The 
enlargement of the particles size is due to the 
doping with Mn. The same structural behavior of 
Mn-doped ZnO nanoparticles was observed in 
XRD results in terms of particles size. Moreover, 
Figure 2 also indicates that the synthesized 
nanoparticles had good crystalline nature. A 
close relationship was observed between the 
results of XRD and SEM. The SEM images 
showed seed-like structures of un-doped ZnO 
and Mn-doped ZnO nanoparticles which are 




EDX studies were carried out in order to examine 
the chemical formation and composition of the 
synthesized nanoparticles and also to confirm 
the presence of un-doped ZnO and Mn-doped 
ZnO nanoparticles. Figures 3 (a) and (b) show 
the EDX spectra for un-doped ZnO and Mn-
doped ZnO nanoparticles, respectively. EDX 
spectra confirmed the presence of the 
constituents zinc (Zn), oxygen (O) in the 
nanoparticles. Hence, EDX spectra affirmed the 
presence of un-doped ZnO and Mn-doped ZnO 
nanoparticles in the synthesized sample. It was 
clear from the EDX pattern that the nanoparticles 
were successfully synthesized. The consistent 
and sharp peaks with zinc oxide and 
manganese-zinc oxide demonstrated that both 
synthesized nanoparticles were crystalline in 
nature, and that peaks associated with impurities 
were absent in EDX spectra of both 
nanoparticles (un-doped ZnO and Mn-doped 
ZnO) [9]. Hence, nanoparticles were obtained in 
their pure forms. 
 
Band gap energy data 
 
Band gap is referred to as energy difference 
between the top valence bands and the bottom 
conduction band. It reflects the ability of electron 




Figure 3: EDX spectrum of un-doped ZnO (a) and Mn-doped ZnO nanoparticles (b) 
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to jump from one band to another. A specific 
minimum amount of energy is required for this 
transition. Measurement of band gap plays a vital 
role in semiconductors. The band gap energy of 
an insulator is large (> 4 eV), but is lower for a 
semiconductor (< 3 eV) [16]. The value of Eg is 
achieved by the intersection between the photon 
energy axis and linear fit. The band gap energy 
of un-doped ZnO nanoparticles was 3.375 eV; 
while for Mn-doped ZnO nanoparticles, band gap 
energy of 2.737 eV was obtained [Figures 4 (a) 
and (b)]. Since t2g level (i.e. the dxy, dxz, and dyz 
orbitals are collectively called the t2g orbitals) of 
Mn is very close to valence bonds (VB) of ZnO, 
the d-electrons of Mn can easily overlap with the 
valence band of ZnO [17]. Being 
semiconductors, the band gap energy of Mn-
doped ZnO nanoparticles should be less than 3 
eV. This is in agreement with the band gap 
energy value for Mn-doped ZnO nanoparticles in 




The results of DPPH radical scavenging assay 
for different concentrations of un-doped ZnO 
nanoparticles are shown in Table 1 in the form of 
IC50 values. The lowest IC50 value (41 ± 0.32 
µg/mL) was seen at a concentration of 1000 
µg/mL, while the highest IC50 value (85 ± 0.23 
µg/mL) was obtained at a concentration of 60 
µg/mL for un-doped ZnO nanoparticles. 
 
 
(a)                                                                        (b) 
Figure 4: Band gap energy data of un-doped ZnO (a) and Mn-doped ZnO nanoparticles (b) 
 
In the case of Mn-doped ZnO nanoparticles, the 
lowest IC50 of 39 ± 0.22 µg/mL was obtained at a 
concentration of 1000 µg/mL and the highest IC50 
of 78 ± 0.25 µg/mL was seen at 60 µg/mL. The 
DPPH free radical scavenging activity increased 
with increasing concentration of the Mn-doped 
ZnO nanoparticles. At a level 1000 µg/mL, Mn-
doped ZnO nanoparticles showed significant 
DPPH radical scavenging activity comparable to 
that of BHT with IC50 value of 48 ± 0.29 µg/mL. 
This indicates that the Mn-doped ZnO 
nanoparticles possess high antioxidant activities 
in terms of scavenging of DPPH free radicals.  
 
High level of total phenolic content (20.1 ± 0.21 
mg/100g GAE) was obtained at a concentration 
of 1000 µg/mL, while the lowest total phenolic 
content (0.95 ± 0.08 mg/100g GAE) was 
observed at 60 µg/mL of un-doped ZnO 
nanoparticles. A similar pattern was seen at 
different concentrations of Mn-doped ZnO 
nanoparticles, although the corresponding values 
were higher when compared with un-doped ZnO 
nanoparticles (the percentage of total phenolic 
contents varied from 1.09 ± 0.18 to 23.1 ± 0.31 
mg/100g GAE at various concentrations i.e. 60 
125, 250, 500 and 1000 µg/mL of Mn-doped ZnO 
nanoparticles). These results are shown in Table 
1, and they indicate that the TPCs of the un-
doped ZnO and Mn-doped ZnO nanoparticles 
were concentration-dependent. The results of 
antioxidant activities of different concentrations of 
un-doped and Mn-doped ZnO nanoparticles, with 
respect to inhibition of linoleic acid oxidation, are 
shown in Table 1. The percentage inhibition 
values of linoleic acid peroxidation were 18 ± 
0.23, 31 ± 0.19, 43 ± 0.15, 50 ± 0.17 and 63 ± 
0.21 at 60, 125, 250, 500 and 1000 µg/mL, 
respectively, for un-doped ZnO nanoparticles. 
Maximum percentage inhibition was 63 ± 0.21% 
(at 1000 µg/mL), while the minimum percentage 
inhibition (18 ± 0.23 %) was recorded at 60 
µg/mL. For Mn-doped ZnO nanoparticles, 
percentage inhibitions varied from 21 ± 0.13 to 
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65 ± 0.11%. Higher inhibition of linoleic acid 
oxidation was observed in Mn-doped ZnO 
nanoparticles than in un-doped ZnO 
nanoparticles. Linoleic oxidation was significantly 
inhibited by the un-doped ZnO and Mn-doped 
ZnO nanoparticles at all the levels tested, and 
the percentage inhibition was comparable to that 
of BHT which produced 61 ± 0.19 % inhibition. 
 
In the FRAP assay, maximum antioxidant activity 
of 8.99 ± 0.21 µM/mL TE was produced by 1000 
µg/mL while minimum antioxidant activity of 0.59 
± 0.01 µM/mL TE was observed with 60 µg/mL of 
un-doped ZnO nanoparticles. The antioxidant 
activity of Mn-doped ZnO nanoparticles varied 
from 0.79±0.11 to 10.9 ± 0.11 µM/mL TE. Higher 
FRAP was exhibited by Mn-doped ZnO 
nanoparticles than un-doped ZnO nanoparticles. 




The results of antibacterial activity of the un-
doped ZnO and Mn-doped ZnO nanoparticles 
are shown in Tables 2 and 3. The un-doped ZnO 
nanoparticles, at 5 mg and at 3 mg exhibited 
significant antibacterial activities against B. 
subtilis, with ZOIs of 17 ± 0.11 mm and 15 ± 0.07 
mm, respectively.  Against Klebsiella, the ZOIs 
were 15 ± 0.05 and 13 ± 0.04 mm, respectively. 
At 5 and 3 mg, the un-doped ZnO nanoparticles 
demonstrated effective bactericidal activity with 
minimum inhibitory concentrations (MICs) of 0.09 
and 0.13 mg/mL, respectively for Klebsiella.  
 
MICs of 0.07 and 0.04 mg/mL were obtained at 3 
mg and at 5 mg, respectively for B. subtilis. 
Compared to the standard drug cephradine (1 
mg), it was evident that 5 mg was much more 
effective for Klebsiella and B. subtilis.  
 
ZOIs of cephradine for Klebsiella and B. subtilis 
were 12±0.05 mm and 14±0.09 mm, 
respectively. Higher bactericidal potential was 
exhibited by Mn-doped ZnO nanoparticles 
relative to the standard drug and un-doped ZnO 
nanoparticles (Table 3). Mn-doped ZnO 
nanoparticles (at 5 mg) produced stronger 
inhibition of the growth of E. coli, S. aureus, 
Klebsiella and B. subtilis, with ZOIs of 13 ± 0.09, 
14 ± 0.01, 18 ± 0.07 and 20 ± 0.10, respectively. 
The MICs of Mn-doped ZnO nanoparticles (at 5 
mg) ranged from 0.03 to 0.09 mg/mL. Thus, the 
Mn-doped ZnO nanoparticles showed very 
effective broad spectrum antibacterial activities. 
 
 
Table 1: Antioxidant activity of synthesized un-doped ZnO and Mn-doped ZnO nanoparticles 
 











M1 NAPs      
1 60 85±0.23 0.59±0.01 0.95±0.08 18±0.23 
2 125 71±0.30 1.88±0.12 2.01±0.11 31±0.19 
3 250 68±0.29 3.01±0.09 5.01±0.15 43±0.15 
4 500 56±0.33 4.68±0.19 11.2±0.25 50±0.17 
5 1000 41±0.32 8.99±0.21 20.1±0.21 63±0.21 
6 BHT 48±0.29 - - 61±0.19 
M2 NAPs      
1 60 78±0.25 0.79±0.11 1.09±0.18 21±0.13 
2 125 65±0.36 2.08±0.02 4.99±0.01 35±0.29 
3 250 58±0.25 4.01±0.19 8.01±0.25 48±0.05 
4 500 49±0.20 7.40±0.09 15.3±0.05 56±0.27 
5 1000 39±0.22 10.9±0.11 23.1±0.31 65±0.11 
6 BHT 48±0.29 - - 61±0.19 
Values are mean ± SD (n = 3); M1 NAPs = un-doped ZnO nanoparticles, M2 NAPs = Mn-doped ZnO 
nanoparticles 
 
Table 2: ZOIs in antibacterial test of un-doped ZnO nanoparticles against different bacterial strains 
 
Bacterial strain 














E. coli 11±0.09 8±0.08 7±0.04 0.30 0.80 0.95 
S. aureus 13±0.05 11±0.11 8±0.09 0.10 0.95 1.01 
Klebsiella 12±0.05 15±0.05 13±0.04 0. 14 0.09 0.13 
B. subtilis 14±0.09 17±0.11 15±0.07 0.08 0.04 0.07 
Values are mean ± SD (n = 3). M1 NAPs = un-doped ZnO nanoparticles, MIC= Minimum inhibition concentration, 
Standard = cephradine 
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Table 3: ZOIs in antibacterial test of Mn-doped ZnO nanoparticles against different bacterial strains 
 
Bacterial strain   













E. coli                   11±0.09 13±0.09 9±0.05 0.30 0.09 0.90 
S. aureus 13±0.07 14±0.01 11±0.08 0.10 0.08 0.85 
Klebsiella 12±0.05 18±0.07 14±0.05 0.14 0.07 0.11 
B. subtilis 14±0.09 20±0.10 17±0.06 0.08 0.03 0.05 
Values are mean ± SD (n = ). M2 NAPs = Mn-doped ZnO nanoparticles, MIC= Minimum inhibition concentration, 




XRD spectra demonstrated that the presence of 
intense and sharp peaks in the XRD spectra of 
the synthesized un-doped ZnO and Mn-doped 
ZnO nanoparticles. This confirmed their 
crystalline nature. The average calculated grain 
size of the un-doped ZnO and Mn-doped ZnO 
nanoparticles were 16.72 and 17.5 nm, 
respectively. These results demonstrate that the 
grain size of the doped ZnO nanoparticles is 
larger than that of the un-doped ZnO 
nanoparticles. This is due to the fact that Mn 
doping results in an increase in grain size. Thus 
the grain size of ZnO nanoparticles was 
increased by Mn doping. The particle size was 
decreased due to increase in the percentage of 
Mn or doping with Mn. These findings are in 
agreement with previous reports [18,19].  
 
SEM results affirmed the nanoscale range of 
particle size for the un-doped ZnO and the Mn-
doped ZnO nanoparticles and also confirmed 
their wurtzite crystalline structures [15]. Results 
from EDX were consistent with those from SEM 
and XRD. The major constituents of the 
nanoparticles were Zn, O and Mn. The strong, 
intense, narrow width and sharp peaks in the 
EDX spectrum indicated that the un-doped ZnO 
and Mn-doped ZnO were crystalline in nature 
[15].  There were agreement and close 
relationship in the results of the various 
characterization techniques, which is an 
indication of successful synthesis of the 
nanoparticles. Band gap data was lower in Mn-
doped ZnO nanoparticles than in the un-doped 
ZnO. This is likely due to the fact that Mn doping 
decreased band gap energy value since the 
band gap energy obtained for the doped product 
was less than 3.0 eV value for semiconductors 
[16,17].  
 
Different concentrations of the synthesized un-
doped ZnO and Mn-doped ZnO were 
investigated for antioxidant potential through total 
antioxidant assays (DPPH radical scavenging, 
FRAP, inhibition of linoleic acid peroxidation and 
TPC). Mn-doped ZnO nanoparticles produced 
better antioxidant results than the un-doped ZnO 
nanoparticles and BHT, while un-doped ZnO 
nanoparticles showed antioxidant activity 
comparable to BHT. This was due to the fact that 
doping with Mn enhanced the antioxidant activity 
of un-doped ZnO nanoparticles [5]. The results 
also revealed that the antioxidant activities of the 
nanoparticles were concentration-dependent 
[12]. These results are consistent with previously 
reported data [8,20,21].  
 
The un-doped ZnO nanoparticles at 5mg 
produced higher antibacterial effects than the 
standard drug cephradine in the inhibition of 
growth of Klebsiella, and Bacillus subtilis, while 
the Mn-doped ZnO nanoparticles exhibited 
greater bactericidal effect in contrast to standard 
drug and un-doped ZnO nanoparticles in 
inhibiting the growth of these organisms. This 
significant bactericidal activity was due to the 
release of Mn+2 ions and Zn+2 from Mn-doped 
ZnO nanoparticles, and the permeation of the 
bacterial cell membrane by these ions. The 
permeation of Mn+2 and Zn+2 ions was possible 
due to the attraction of their positive charges to 
the negatively-charged cell wall. The binding of 
these ions destroyed the bacterial cell 
membrane. In addition, Mn+2 ions and Zn+2 ions 
are involved in cross-linkage of nucleic acid 
strands by binding with DNA molecules of 
bacteria. This produces a disorder in the DNA 
structure, leading to protein denaturation and 





The results of this study indicate that although 
the synthesized un-doped ZnO nanoparticles 
possess potent and desirable biological 
properties such as antibacterial and antioxidant 
activities, Mn-doped ZnO nanoparticles showed 
better results than un-doped ZnO nanoparticles. 
This is due to the large surface and smaller 
particle size of Mn-doped nanoparticles. Thus, 
the synthesized nanoparticles hold enormous 
potential for use in the cosmetic, nutraceutical 
and pharmaceutical industries. 
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